Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Stroke

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 118 articles:
HTML format



Single Articles


    July 2021
  1. FUKAYA H, Ako J, Yasuda S, Kaikita K, et al
    Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319321. doi: 10.1136/heartjnl-2021-319321
    PubMed     Abstract available


    May 2021
  2. DAGENAIS GR, Dyal L, Bosch JJ, Leong DP, et al
    Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease.
    Heart. 2021 May 21. pii: heartjnl-2020-318758. doi: 10.1136/heartjnl-2020-318758
    PubMed     Abstract available


  3. CHOI Y, Lee Y, Kim SH, Kim S, et al
    Single direct oral anticoagulant therapy in stable patients with atrial fibrillation beyond 1 year after coronary stent implantation.
    Heart. 2021 May 14. pii: heartjnl-2020-318750. doi: 10.1136/heartjnl-2020-318750
    PubMed     Abstract available


  4. PARK J, Yoon YE, Kim KM, Hwang IC, et al
    Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women.
    Heart. 2021 May 7. pii: heartjnl-2020-318764. doi: 10.1136/heartjnl-2020-318764.
    PubMed     Abstract available


    April 2021
  5. BUCHAN TA, Malik A, Chan C, Chambers J, et al
    Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses.
    Heart. 2021 Apr 8. pii: heartjnl-2021-319243. doi: 10.1136/heartjnl-2021-319243.
    PubMed     Abstract available


  6. SPARROW R, Sanjoy S, Choi YH, Elgendy IY, et al
    Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure.
    Heart. 2021 Apr 1. pii: heartjnl-2020-318650. doi: 10.1136/heartjnl-2020-318650.
    PubMed     Abstract available


    March 2021
  7. MELDUNI R, Nkomo VT, Wysokinski W, Gersh BJ, et al
    Risk of left atrial appendage thrombus and stroke in patients with atrial fibrillation and mitral regurgitation.
    Heart. 2021 Mar 25. pii: heartjnl-2020-317659. doi: 10.1136/heartjnl-2020-317659
    PubMed     Abstract available


    January 2021
  8. BOSSARD M, Gao P, Boden W, Steg G, et al
    Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease.
    Heart. 2021 Jan 27. pii: heartjnl-2020-318045. doi: 10.1136/heartjnl-2020-318045
    PubMed     Abstract available


  9. MALLINSON PAC, Luhar S, Williamson E, Barreto ML, et al
    Socioeconomic position and cardiovascular mortality in 63 million adults from Brazil.
    Heart. 2021 Jan 22. pii: heartjnl-2020-318153. doi: 10.1136/heartjnl-2020-318153
    PubMed     Abstract available


  10. MARCUSCHAMER I, Zusman O, Iakobishvili Z, Assali AR, et al
    Outcome of patients with prior coronary bypass surgery admitted with an acute coronary syndrome.
    Heart. 2021 Jan 18. pii: heartjnl-2020-318047. doi: 10.1136/heartjnl-2020-318047
    PubMed     Abstract available


  11. MAZNYCZKA AM, McCartney P, Duklas P, McEntegart M, et al
    Effect of coronary flow on intracoronary alteplase: a prespecified analysis from a randomised trial.
    Heart. 2021 Jan 12. pii: heartjnl-2020-317828. doi: 10.1136/heartjnl-2020-317828
    PubMed     Abstract available


  12. VASCONCELOS M, Vasconcelos L, Ribeiro V, Campos C, et al
    Incidence and predictors of stroke in patients with rheumatic heart disease.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318054. doi: 10.1136/heartjnl-2020-318054.
    PubMed     Abstract available


  13. WU J, Mamas MA, Mohamed MO, Kwok CS, et al
    Place and causes of acute cardiovascular mortality during the COVID-19 pandemic.
    Heart. 2021;107:113-119.
    PubMed     Abstract available


  14. SINGH T, Newby DE
    Is the fear of disease worse than the disease itself?
    Heart. 2021;107:91-92.
    PubMed    


    December 2020
  15. O' DONNELL M, Hankey GJ, Rangarajan S, Chin SL, et al
    Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level.
    Heart. 2020 Dec 14. pii: heartjnl-2019-316515. doi: 10.1136/heartjnl-2019-316515
    PubMed     Abstract available


  16. GARCIA RODRIGUEZ LA, Cea Soriano L, Munk Hald S, Hallas J, et al
    Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke.
    Heart. 2020 Dec 11. pii: heartjnl-2020-317887. doi: 10.1136/heartjnl-2020-317887
    PubMed     Abstract available


  17. HANON O, Vidal JS, Pisica-Donose G, Orvoen G, et al
    Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation.
    Heart. 2020 Dec 1. pii: heartjnl-2020-317923. doi: 10.1136/heartjnl-2020-317923.
    PubMed     Abstract available


    November 2020
  18. SANJOY S, Choi YH, Holmes D, Herrman H, et al
    Comorbidity burden in patients undergoing left atrial appendage closure.
    Heart. 2020 Nov 23. pii: heartjnl-2020-317741. doi: 10.1136/heartjnl-2020-317741
    PubMed     Abstract available


    October 2020
  19. SEIFFGE DJ, Meinel TR
    The real prize of direct oral anticoagulant blockbuster.
    Heart. 2020 Oct 28. pii: heartjnl-2020-318092. doi: 10.1136/heartjnl-2020-318092
    PubMed    


  20. BOYLE PM, Del Alamo JC, Akoum N
    Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models.
    Heart. 2020 Oct 23. pii: heartjnl-2020-317455. doi: 10.1136/heartjnl-2020-317455
    PubMed     Abstract available


    August 2020
  21. KJERPESETH LJ, Igland J, Selmer R, Ellekjaer H, et al
    Prevalence and incidence rates of atrial fibrillation in Norway 2004-2014.
    Heart. 2020 Aug 20. pii: heartjnl-2020-316624. doi: 10.1136/heartjnl-2020-316624
    PubMed     Abstract available


  22. MAEDA T, Nishi T, Funakoshi S, Tada K, et al
    Residual risks of ischaemic stroke and systemic embolism among atrial fibrillation patients with anticoagulation: large-scale real-world data (F-CREATE project).
    Heart. 2020 Aug 14. pii: heartjnl-2020-317299. doi: 10.1136/heartjnl-2020-317299
    PubMed     Abstract available


  23. HENDRIKS J, Gallagher C, Nyfort-Hansen K, Lau D, et al
    Adherence to anticoagulation therapy in patients with atrial fibrillation: is a tailored team-based approach warranted?
    Heart. 2020 Aug 7. pii: heartjnl-2020-317478. doi: 10.1136/heartjnl-2020-317478.
    PubMed    


    July 2020
  24. DING WY, Gupta D, Lip GYH
    Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.
    Heart. 2020 Jul 16. pii: heartjnl-2020-316977. doi: 10.1136/heartjnl-2020-316977
    PubMed     Abstract available


  25. LYCKHAGE LF, Hansen ML, Toft JC, Larsen SL, et al
    Continuous electrocardiography for detecting atrial fibrillation beyond 1 year after stroke in primary care.
    Heart. 2020 Jul 3. pii: heartjnl-2020-316904. doi: 10.1136/heartjnl-2020-316904.
    PubMed     Abstract available


    May 2020
  26. AL SAID S, Katus HA, Alabed S
    Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention.
    Heart. 2020 May 29. pii: heartjnl-2020-316726. doi: 10.1136/heartjnl-2020-316726
    PubMed    


  27. BURDEN AF
    Tub bathing and heart disease.
    Heart. 2020;106:710.
    PubMed    


    April 2020
  28. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    PubMed     Abstract available


  29. CHATEAUNEUF G, Nazif TM, Beaupre F, Kodali S, et al
    Cerebrovascular events after transcatheter mitral valve interventions: a systematic review and meta-analysis.
    Heart. 2020 Apr 17. pii: heartjnl-2019-316331. doi: 10.1136/heartjnl-2019-316331
    PubMed     Abstract available


  30. OTTO CM
    Heartbeat: risk of stroke in patients with heart failure.
    Heart. 2020;106:549-551.
    PubMed    


    March 2020
  31. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available


  32. UKAI T, Iso H, Yamagishi K, Saito I, et al
    Habitual tub bathing and risks of incident coronary heart disease and stroke.
    Heart. 2020 Mar 24. pii: heartjnl-2019-315752. doi: 10.1136/heartjnl-2019-315752
    PubMed     Abstract available


  33. YAO X, Noseworthy P
    NOAC dosing and monitoring: really as simple as it seems?
    Heart. 2020;106:321-322.
    PubMed    


    February 2020
  34. KIM JY, Kim SH, Myong JP, Choi Y, et al
    Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea.
    Heart. 2020 Feb 6. pii: heartjnl-2019-315883. doi: 10.1136/heartjnl-2019-315883.
    PubMed     Abstract available


    January 2020
  35. NELSON AJ, Patel MR
    Ischaemic stroke in heart failure: back to basics?
    Heart. 2020 Jan 27. pii: heartjnl-2019-315957. doi: 10.1136/heartjnl-2019-315957
    PubMed    


  36. LU J, Zhang L, Lu Y, Su M, et al
    Secondary prevention of cardiovascular disease in China.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315884. doi: 10.1136/heartjnl-2019-315884
    PubMed     Abstract available


  37. TAN TC, Nunes MCP, Handschumacher M, Pontes-Neto O, et al
    Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
    Heart. 2020 Jan 24. pii: heartjnl-2019-315964. doi: 10.1136/heartjnl-2019-315964
    PubMed     Abstract available


    November 2019
  38. CHRISTERSSON C, James SK, Lindhagen L, Ahlsson A, et al
    Comparison of warfarin versus antiplatelet therapy after surgical bioprosthetic aortic valve replacement.
    Heart. 2019 Nov 22. pii: heartjnl-2019-315453. doi: 10.1136/heartjnl-2019-315453
    PubMed     Abstract available


    October 2019
  39. YU CW
    Does thrombectomy inhibit effect of ischaemic postconditioning in STEMI? True or not?
    Heart. 2019 Oct 14. pii: heartjnl-2019-315389. doi: 10.1136/heartjnl-2019-315389
    PubMed    


  40. BANERJEE A, Benedetto V, Gichuru P, Burnell J, et al
    Adherence and persistence to direct oral anticoagulants in atrial fibrillation: a population-based study.
    Heart. 2019 Oct 10. pii: heartjnl-2019-315307. doi: 10.1136/heartjnl-2019-315307
    PubMed     Abstract available


  41. CHOU YL, Liou JT, Cheng CC, Tsai MC, et al
    The association of ischaemic stroke in patients with heart failure without atrial flutter/fibrillation.
    Heart. 2019 Oct 3. pii: heartjnl-2019-315646. doi: 10.1136/heartjnl-2019-315646.
    PubMed     Abstract available


    September 2019
  42. WU VC, Wu M, Aboyans V, Chang SH, et al
    Female sex as a risk factor for ischaemic stroke varies with age in patients with atrial fibrillation.
    Heart. 2019 Sep 26. pii: heartjnl-2019-315065. doi: 10.1136/heartjnl-2019-315065
    PubMed     Abstract available


  43. JAME S, Barnes G
    Stroke and thromboembolism prevention in atrial fibrillation.
    Heart. 2019 Sep 18. pii: heartjnl-2019-314898. doi: 10.1136/heartjnl-2019-314898
    PubMed     Abstract available


    August 2019
  44. FROEHLICH L, Meyre P, Aeschbacher S, Blum S, et al
    Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315174. doi: 10.1136/heartjnl-2019-315174
    PubMed     Abstract available


    July 2019
  45. NEPPER-CHRISTENSEN L, Hofsten DE, Helqvist S, Lassen JF, et al
    Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.
    Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952
    PubMed     Abstract available


  46. SCHAUFELBERGER M
    Cardiomyopathy and pregnancy.
    Heart. 2019 Jul 15. pii: heartjnl-2018-313476. doi: 10.1136/heartjnl-2018-313476
    PubMed     Abstract available


    June 2019
  47. MALIK AH, Yandrapalli S, Aronow WS, Panza JA, et al
    Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves.
    Heart. 2019 Jun 14. pii: heartjnl-2019-314767. doi: 10.1136/heartjnl-2019-314767
    PubMed     Abstract available


    May 2019
  48. LINDHOLM D, Sarno G, Erlinge D, Svennblad B, et al
    Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction.
    Heart. 2019 May 4. pii: heartjnl-2018-314590. doi: 10.1136/heartjnl-2018-314590.
    PubMed     Abstract available


    April 2019
  49. BEGGS SAS, Rorth R, Gardner RS, McMurray JJV, et al
    Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314381. doi: 10.1136/heartjnl-2018-314381.
    PubMed     Abstract available


    March 2019
  50. SEJR MH, May O, Damgaard D, Sandal BF, et al
    External continuous ECG versus loop recording for atrial fibrillation detection in patients who had a stroke.
    Heart. 2019 Mar 21. pii: heartjnl-2018-314186. doi: 10.1136/heartjnl-2018-314186
    PubMed     Abstract available


  51. POKORNEY SD, Lopes RD
    Atrial fibrillation: what do we know about screening and what do we not know about treatment?
    Heart. 2019 Mar 21. pii: heartjnl-2018-314518. doi: 10.1136/heartjnl-2018-314518
    PubMed    


    January 2019
  52. MAZLAN-KEPLI W, Dawson J, Berry C, Walters M, et al
    Cessation of dual antiplatelet therapy and cardiovascular events following acute coronary syndrome.
    Heart. 2019;105:67-74.
    PubMed     Abstract available


    November 2018
  53. FAN JH, Wang JB, Wang SM, Abnet CC, et al
    Longitudinal change in blood pressure is associated with cardiovascular disease mortality in a Chinese cohort.
    Heart. 2018;104:1764-1771.
    PubMed     Abstract available


    October 2018
  54. BERNTSSON J, Smith JG, Johnson LSB, Soderholm M, et al
    Increased vascular endothelial growth factor D is associated with atrial fibrillation and ischaemic stroke.
    Heart. 2018 Oct 16. pii: heartjnl-2018-313684. doi: 10.1136/heartjnl-2018-313684
    PubMed     Abstract available


    September 2018
  55. NTILOUDI D, Apostolopoulou S, Vasiliadis K, Frogoudaki A, et al
    Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease.
    Heart. 2018 Sep 29. pii: heartjnl-2018-313613. doi: 10.1136/heartjnl-2018-313613
    PubMed     Abstract available


  56. LEE SE, Lee HY, Cho HJ, Choe WS, et al
    Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313242. doi: 10.1136/heartjnl-2018-313242
    PubMed     Abstract available


  57. CHRISTERSSON C, Wallentin L, Andersson U, Alexander JH, et al
    Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313351. doi: 10.1136/heartjnl-2018-313351
    PubMed     Abstract available


  58. OTTO CM
    Heartbeat: Social isolation is associated with increased mortality after acute myocardial infarction or stroke.
    Heart. 2018;104:1471-1473.
    PubMed    


    July 2018
  59. SANDHU RK, Ezekowitz JA
    Is incentivising stroke prevention therapy in atrial fibrillation the key?
    Heart. 2018 Jul 10. pii: heartjnl-2018-313402. doi: 10.1136/heartjnl-2018-313402
    PubMed    


  60. ADDERLEY NJ, Ryan R, Nirantharakumar K, Marshall T, et al
    Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016.
    Heart. 2018 Jul 10. pii: heartjnl-2018-312977. doi: 10.1136/heartjnl-2018-312977
    PubMed     Abstract available


  61. OTTO CM
    Heartbeat: cardiovascular disease risk and reproductive factors in women.
    Heart. 2018;104:1045-1047.
    PubMed    


  62. PETERS SA, Woodward M
    Women's reproductive factors and incident cardiovascular disease in the UK Biobank.
    Heart. 2018;104:1069-1075.
    PubMed     Abstract available


  63. JARVIE JL, Metz TD, Davis MB, Ehrig JC, et al
    Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy.
    Heart. 2018;104:1187-1194.
    PubMed     Abstract available


    June 2018
  64. ZHU K, Knuiman M, Divitini M, Murray K, et al
    High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
    Heart. 2018;104:895-903.
    PubMed     Abstract available


    May 2018
  65. QIN C, Lv J, Guo Y, Bian Z, et al
    Associations of egg consumption with cardiovascular disease in a cohort study of 0.5 million Chinese adults.
    Heart. 2018 May 21. pii: heartjnl-2017-312651. doi: 10.1136/heartjnl-2017-312651
    PubMed     Abstract available


    April 2018
  66. KIM D, Yang PS, Jang E, Yu HT, et al
    Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015.
    Heart. 2018 Apr 17. pii: heartjnl-2017-312930. doi: 10.1136/heartjnl-2017-312930
    PubMed     Abstract available


  67. LARSSON SC, Drca N, Bjorck M, Back M, et al
    Nut consumption and incidence of seven cardiovascular diseases.
    Heart. 2018 Apr 16. pii: heartjnl-2017-312819. doi: 10.1136/heartjnl-2017-312819
    PubMed     Abstract available


  68. BISSON A, Bodin A, Fauchier L
    Why and how to screen for atrial fibrillation.
    Heart. 2018 Apr 5. pii: heartjnl-2018-313085. doi: 10.1136/heartjnl-2018-313085.
    PubMed    


  69. VIZZI V, Di Biasi M, Alessandrino G, Colombo A, et al
    Left atrial appendage occlusion in high-risk patients: doing it is better than nothing.
    Heart. 2018;104:625.
    PubMed    


  70. MASOUD A, Bartoletti S, Fairbairn T, Khurana A, et al
    Outcome of left atrial appendage occlusion in high-risk patients.
    Heart. 2018;104:594-599.
    PubMed     Abstract available


  71. GIANNAKOULAS G, Ntiloudi D
    Acquired cardiovascular disease in adult patients with congenital heart disease.
    Heart. 2018;104:546-547.
    PubMed    


    March 2018
  72. LINKER DT, Murphy TB, Mokdad AH
    Selective screening for atrial fibrillation using multivariable risk models.
    Heart. 2018 Mar 28. pii: heartjnl-2017-312686. doi: 10.1136/heartjnl-2017-312686
    PubMed     Abstract available


  73. HAKULINEN C, Pulkki-Raback L, Virtanen M, Jokela M, et al
    Social isolation and loneliness as risk factors for myocardial infarction, stroke and mortality: UK Biobank cohort study of 479 054 men and women.
    Heart. 2018 Mar 27. pii: heartjnl-2017-312663. doi: 10.1136/heartjnl-2017-312663
    PubMed     Abstract available


  74. EDFORS R, Sahlen A, Szummer K, Renlund H, et al
    Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function.
    Heart. 2018 Mar 24. pii: heartjnl-2017-312436. doi: 10.1136/heartjnl-2017-312436
    PubMed     Abstract available


  75. LAUNEY Y, Seguin P
    Is traumatic intracranial haemorrhage a specific risk factor for atrial fibrillation?
    Heart. 2018;104:450.
    PubMed    


    February 2018
  76. FERRARIO MM, Roncaioli M, Veronesi G, Holtermann A, et al
    Differing associations for sport versus occupational physical activity and cardiovascular risk.
    Heart. 2018 Feb 9. pii: heartjnl-2017-312594. doi: 10.1136/heartjnl-2017-312594.
    PubMed     Abstract available


  77. COWIE MR, Zakeri R
    Preventing stroke in patients with heart failure: why are patients losing out?
    Heart. 2018 Feb 2. pii: heartjnl-2017-312862. doi: 10.1136/heartjnl-2017-312862.
    PubMed    


  78. ADAMSON PD, Hunter A, Williams MC, Shah ASV, et al
    Diagnostic and prognostic benefits of computed tomography coronary angiography using the 2016 National Institute for Health and Care Excellence guidance within a randomised trial.
    Heart. 2018;104:207-214.
    PubMed     Abstract available


    January 2018
  79. SAVARESE G, Sartipy U, Friberg L, Dahlstrom U, et al
    Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312720. doi: 10.1136/heartjnl-2017-312720
    PubMed     Abstract available


  80. VINEREANU D, Wang A, Mulder H, Lopes RD, et al
    Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease.
    Heart. 2018 Jan 19. pii: heartjnl-2017-312272. doi: 10.1136/heartjnl-2017-312272
    PubMed     Abstract available


  81. SMILOWITZ NR, Gupta N, Guo Y, Beckman JA, et al
    Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgery.
    Heart. 2018 Jan 5. pii: heartjnl-2017-312391. doi: 10.1136/heartjnl-2017-312391.
    PubMed     Abstract available


  82. BAENA-DIEZ JM, Garcia-Gil M, Comas-Cufi M, Ramos R, et al
    Association between chronic immune-mediated inflammatory diseases and cardiovascular risk.
    Heart. 2018;104:119-126.
    PubMed     Abstract available


    December 2017
  83. GNANENTHIRAN SR, Kritharides L, D'Souza M, Lowe HC, et al
    Revascularisation compared with initial medical therapy for non-ST-elevation acute coronary syndromes in the elderly: a meta-analysis.
    Heart. 2017;103:1962-1969.
    PubMed     Abstract available


  84. OTTO CM
    Heartbeat: Healthcare approaches to reducing adverse outcomes in patients with atrial fibrillation.
    Heart. 2017;103:1925-1927.
    PubMed    


    November 2017
  85. KIM TH, Kim H, Kim IC, Yoon HJ, et al
    Heart rate at first postdischarge visit and outcomes in patients with heart failure.
    Heart. 2017 Nov 25. pii: heartjnl-2017-312364. doi: 10.1136/heartjnl-2017-312364
    PubMed     Abstract available


  86. TOYOTA T, Morimoto T, Shiomi H, Yamaji K, et al
    Single-session versus staged procedures for elective multivessel percutaneous coronary intervention.
    Heart. 2017 Nov 16. pii: heartjnl-2017-312117. doi: 10.1136/heartjnl-2017-312117
    PubMed     Abstract available


  87. BAI L, Li Q, Wang J, Lavigne E, et al
    Increased coronary heart disease and stroke hospitalisations from ambient temperatures in Ontario.
    Heart. 2017 Nov 3. pii: heartjnl-2017-311821. doi: 10.1136/heartjnl-2017-311821.
    PubMed     Abstract available


    August 2017
  88. BOKMA JP, Zegstroo I, Kuijpers JM, Konings TC, et al
    Factors associated with coronary artery disease and stroke in adults with congenital heart disease.
    Heart. 2017 Aug 28. pii: heartjnl-2017-311620. doi: 10.1136/heartjnl-2017-311620
    PubMed     Abstract available


  89. KAUFMAN BG, Kim S, Pieper K, Allen LA, et al
    Disease understanding in patients newly diagnosed with atrial fibrillation.
    Heart. 2017 Aug 8. pii: heartjnl-2017-311800. doi: 10.1136/heartjnl-2017-311800.
    PubMed     Abstract available


  90. LIM WY, Lloyd G, Bhattacharyya S
    Mechanical and surgical bioprosthetic valve thrombosis.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311856. doi: 10.1136/heartjnl-2017-311856.
    PubMed     Abstract available


    June 2017
  91. GHANNAM M, Chugh A
    Indications and appropriate selection of novel oral anticoagulants in patients with atrial fibrillation.
    Heart. 2017 Jun 17. pii: heartjnl-2014-307030. doi: 10.1136/heartjnl-2014-307030
    PubMed    


  92. ISAEW A, Adderley NJ, Ryan R, Fitzmaurice D, et al
    The treatment of paroxysmal atrial fibrillation in UK primary care.
    Heart. 2017 Jun 1. pii: heartjnl-2016-310927. doi: 10.1136/heartjnl-2016-310927.
    PubMed     Abstract available


  93. POTPARA TS, Lip GY
    Drug-induced liver injury with oral anticoagulants: a threat or not?
    Heart. 2017;103:809-811.
    PubMed    


    April 2017
  94. HENDRIKS JM, Gallagher C, Sanders P
    Ensuring adherence to therapy with anticoagulation in patients with atrial fibrillation.
    Heart. 2017 Apr 7. pii: heartjnl-2017-311305. doi: 10.1136/heartjnl-2017-311305.
    PubMed    


    March 2017
  95. JACKEVICIUS CA, Tsadok MA, Essebag V, Atzema C, et al
    Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation.
    Heart. 2017 Mar 12. pii: heartjnl-2016-310672. doi: 10.1136/heartjnl-2016-310672
    PubMed     Abstract available


  96. VOUKALIS C, Lip GY
    Oral anticoagulation for elderly patients with non-valvular atrial fibrillation: recent insights from randomised trials and the 'real world'.
    Heart. 2017 Mar 3. pii: heartjnl-2017-311162. doi: 10.1136/heartjnl-2017-311162.
    PubMed    


  97. CAVALCANTE R, Sotomi Y, Zeng Y, Lee CW, et al
    Coronary bypass surgery versus stenting in multivessel disease involving the proximal left anterior descending coronary artery.
    Heart. 2017;103:428-433.
    PubMed     Abstract available


    February 2017
  98. LAUW MN, Eikelboom JW, Coppens M, Wallentin L, et al
    Effects of dabigatran according to age in atrial fibrillation.
    Heart. 2017 Feb 17. pii: heartjnl-2016-310358. doi: 10.1136/heartjnl-2016-310358
    PubMed     Abstract available


    January 2017
  99. OTTO CM
    Heartbeat: Left atrial appendage occlusion for stroke prevention.
    Heart. 2017;103:89-90.
    PubMed    


  100. KIRCHHOF P
    Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines.
    Heart. 2017 Jan 11. pii: heartjnl-2016-310843. doi: 10.1136/heartjnl-2016-310843
    PubMed    


  101. BLACK-MAIER E, Piccini JP
    Oral anticoagulation in end-stage renal disease and atrial fibrillation: is it time to just say no to drugs?
    Heart. 2017 Jan 9. pii: heartjnl-2016-310540. doi: 10.1136/heartjnl-2016-310540.
    PubMed    


    December 2016
  102. WILLIAMS RB
    Loneliness and social isolation and increased risk of coronary heart disease and stroke: clinical implications.
    Heart. 2016;102:2016.
    PubMed    


    November 2016
  103. YANG F, Hellyer JA, Than C, Ullal AJ, et al
    Warfarin utilisation and anticoagulation control in patients with atrial fibrillation and chronic kidney disease.
    Heart. 2016 Nov 15. pii: heartjnl-2016-309266. doi: 10.1136/heartjnl-2016-309266
    PubMed     Abstract available


    October 2016
  104. BAHIT MC, Lopes RD, Wojdyla DM, Held C, et al
    Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
    Heart. 2016 Oct 24. pii: heartjnl-2016-309901. doi: 10.1136/heartjnl-2016-309901
    PubMed     Abstract available


    September 2016
  105. HEIDBUCHEL H
    The search for the tipping point on when to anticoagulate patients with atrial fibrillation.
    Heart. 2016 Sep 20. pii: heartjnl-2016-310325. doi: 10.1136/heartjnl-2016-310325
    PubMed    


  106. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    PubMed     Abstract available


  107. CAMM AJ, Accetta G, Ambrosio G, Atar D, et al
    Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309832. doi: 10.1136/heartjnl-2016-309832
    PubMed     Abstract available


  108. SWAANS MJ, Boersma LV
    Atrial appendage occlusion for stroke prevention in patients with atrial fibrillation.
    Heart. 2016 Sep 13. pii: heartjnl-2016-310198. doi: 10.1136/heartjnl-2016-310198
    PubMed    


  109. MAZUREK M, Lip GY
    To occlude or not? Left atrial appendage occlusion for stroke prevention in atrial fibrillation.
    Heart. 2016 Sep 12. pii: heartjnl-2016-310255. doi: 10.1136/heartjnl-2016-310255
    PubMed    


  110. SAHAY S, Nombela-Franco L, Rodes-Cabau J, Jimenez-Quevedo P, et al
    Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Heart. 2016 Sep 1. pii: heartjnl-2016-309782. doi: 10.1136/heartjnl-2016-309782.
    PubMed     Abstract available


    August 2016
  111. ALLAN V, Banerjee A, Shah AD, Patel R, et al
    Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care.
    Heart. 2016 Aug 31. pii: heartjnl-2016-309910. doi: 10.1136/heartjnl-2016-309910
    PubMed     Abstract available


  112. PURI R, Byrne J, Muller R, Baumbach H, et al
    Transcatheter aortic valve implantation in patients with small aortic annuli using a 20 mm balloon-expanding valve.
    Heart. 2016 Aug 17. pii: heartjnl-2016-309707. doi: 10.1136/heartjnl-2016-309707
    PubMed     Abstract available


  113. AYABE K, Goto S
    Comparative registries of atrial fibrillation from Japan and the UK: is there a difference between the east and west ends of the Eurasian continent?
    Heart. 2016 Aug 12. pii: heartjnl-2016-310024. doi: 10.1136/heartjnl-2016-310024
    PubMed    


  114. BERTI S, Pastormerlo LE, Rezzaghi M, Trianni G, et al
    Left atrial appendage occlusion in high-risk patients with non-valvular atrial fibrillation.
    Heart. 2016 Aug 4. pii: heartjnl-2015-309150. doi: 10.1136/heartjnl-2015-309150.
    PubMed     Abstract available


    June 2016
  115. SENOO K, An Y, Ogawa H, Lane DA, et al
    Stroke and death in elderly patients with atrial fibrillation in Japan compared with the United Kingdom.
    Heart. 2016 Jun 16. pii: heartjnl-2016-309741. doi: 10.1136/heartjnl-2016-309741
    PubMed     Abstract available


  116. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Abstract available


    February 2016
  117. BATRA G, Svennblad B, Held C, Jernberg T, et al
    All types of atrial fibrillation in the setting of myocardial infarction are associated with impaired outcome.
    Heart. 2016 Feb 29. pii: heartjnl-2015-308678. doi: 10.1136/heartjnl-2015-308678
    PubMed     Abstract available


  118. BREITHARDT G, Baumgartner H, Berkowitz SD, Hellkamp AS, et al
    Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban.
    Heart. 2016 Feb 17. pii: heartjnl-2015-308120. doi: 10.1136/heartjnl-2015-308120
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Stroke is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: